-
Plant-based vaccines challenge big pharma
The recent revelation that the Ebola drug ZMapp is produced in the leaves of tobacco plants captured global attention.
- Categories
- Health Care
-
GlaxoSmithKline, NewLink working to bring Ebola vaccines online: WHO
Both GlaxoSmithKline and NewLink Genetics are working to boost their capacity to make Ebola vaccines, with a goal of a "very significant increase in scale during the first half of 2015," the World Health Organization said on Wednesday.
- Categories
- Health Care
-
Handling the next pandemic
Can the global health system stop Ebola? The answer has more to do with Samuel Kaziraho than you might expect.
- Categories
- Health Care
-
Developing countries should enroll medical and nursing students from rural areas
Nearly one third of medical and nursing students in developing countries may have no intention of working in their own countries after graduation, while less than one fifth of them intend to work in rural areas where they are needed most, according to a new study.
- Categories
- Education, Health Care
- Region
- Sub-Saharan Africa
-
Ebola Researchers Have A Radical Idea: Rush A Vaccine Into The Field
Traditional means of containing Ebola aren't working fast enough to get ahead of the epidemic. So the question is: Will giving an experimental vaccine to willing volunteers help contain the disease or put people at greater risk?
- Categories
- Education, Health Care
- Region
- Sub-Saharan Africa
-
Shares of Companies Testing Ebola Vaccines Rise
Shares of some companies that are studying potential vaccines for Ebola climbed after federal officials announced that the first case of the disease has been diagnosed in the U.S.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Mobile technology offers option to combat fake drugs in West Africa
Cholera, malaria and the rapidly expanding threat of Ebola have hit African countries with a related health-care problem: the scourge of fake drugs.
- Categories
- Health Care, Technology
- Region
- Sub-Saharan Africa
-
OPINION: Ebola and Irrational Exuberance for Social Impact Bonds and Social Enterprise
The lack of preventative action against Ebola isn’t just market failure, and effective action against public health crises in West Africa are unlikely to be addressed by private investors putting money into social impact bonds.
- Categories
- Health Care
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.